These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 3053748

  • 1. Peripheral insulin parallels changes in insulin secretion more closely than C-peptide after bolus intravenous glucose administration.
    Shapiro ET, Tillil H, Rubenstein AH, Polonsky KS.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1094-9. PubMed ID: 3053748
    [Abstract] [Full Text] [Related]

  • 2. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET, Van Cauter E, Tillil H, Given BD, Hirsch L, Beebe C, Rubenstein AH, Polonsky KS.
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [Abstract] [Full Text] [Related]

  • 3. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus.
    Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel G, Henry RR.
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885
    [Abstract] [Full Text] [Related]

  • 4. Oscillations in insulin secretion during constant glucose infusion in normal man: relationship to changes in plasma glucose.
    Shapiro ET, Tillil H, Polonsky KS, Fang VS, Rubenstein AH, Van Cauter E.
    J Clin Endocrinol Metab; 1988 Aug; 67(2):307-14. PubMed ID: 3292558
    [Abstract] [Full Text] [Related]

  • 5. Insulin secretion and clearance. Comparison after oral and intravenous glucose.
    Shapiro ET, Tillil H, Miller MA, Frank BH, Galloway JA, Rubenstein AH, Polonsky KS.
    Diabetes; 1987 Dec; 36(12):1365-71. PubMed ID: 3315785
    [Abstract] [Full Text] [Related]

  • 6. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients.
    Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B.
    J Clin Invest; 1986 Jan; 77(1):98-105. PubMed ID: 3511094
    [Abstract] [Full Text] [Related]

  • 7. Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans.
    Tillil H, Shapiro ET, Miller MA, Karrison T, Frank BH, Galloway JA, Rubenstein AH, Polonsky KS.
    Am J Physiol; 1988 Mar; 254(3 Pt 1):E349-57. PubMed ID: 3279811
    [Abstract] [Full Text] [Related]

  • 8. Reduction of insulin clearance during hyperglycemic clamp. Dose-response study in normal humans.
    Tillil H, Shapiro ET, Rubenstein AH, Galloway JA, Polonsky KS.
    Diabetes; 1988 Oct; 37(10):1351-7. PubMed ID: 3046967
    [Abstract] [Full Text] [Related]

  • 9. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance.
    Van Cauter E, Mestrez F, Sturis J, Polonsky KS.
    Diabetes; 1992 Mar; 41(3):368-77. PubMed ID: 1551497
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
    Nauck M, Schmidt WE, Ebert R, Strietzel J, Cantor P, Hoffmann G, Creutzfeldt W.
    J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
    [Abstract] [Full Text] [Related]

  • 12. Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans.
    Filipsson K, Tornøe K, Holst J, Ahrén B.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3093-8. PubMed ID: 9284750
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quantitative study of insulin secretion and clearance in normal and obese subjects.
    Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, Van Cauter E.
    J Clin Invest; 1988 Feb; 81(2):435-41. PubMed ID: 3276729
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N.
    Eur J Med Res; 2003 Jul 31; 8(7):295-303. PubMed ID: 12911866
    [Abstract] [Full Text] [Related]

  • 18. Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals.
    Jones CN, Pei D, Staris P, Polonsky KS, Chen YD, Reaven GM.
    J Clin Endocrinol Metab; 1997 Jun 31; 82(6):1834-8. PubMed ID: 9177392
    [Abstract] [Full Text] [Related]

  • 19. Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
    Garvey WT, Revers RR, Kolterman OG, Rubenstein AH, Olefsky JM.
    J Clin Endocrinol Metab; 1985 Mar 31; 60(3):559-68. PubMed ID: 3882736
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.